Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 987,000 | 560,000 | 1,230,000 | 1,158,000 | 1,605,000 |
Receivables | 1,473,000 | 1,255,000 | 1,382,000 | 1,520,000 | 1,421,000 |
Inventories | 205,000 | 199,000 | 223,000 | 223,000 | 205,000 |
TOTAL | $2,854,000 | $2,146,000 | $2,999,000 | $3,058,000 | $3,348,000 |
Non-Current Assets | |||||
PPE Net | 1,634,000 | 1,622,000 | 1,624,000 | 1,627,000 | 1,544,000 |
Investments And Advances | 124,000 | 111,000 | 527,000 | 521,000 | 480,000 |
Intangibles | 8,209,000 | 8,217,000 | 8,011,000 | 8,040,000 | 8,072,000 |
Other Non-Current Assets | 751,000 | 765,000 | 770,000 | 780,000 | 699,000 |
TOTAL | $10,718,000 | $10,715,000 | $10,932,000 | $10,968,000 | $10,795,000 |
Total Assets | $13,572,000 | $12,861,000 | $13,931,000 | $14,026,000 | $14,143,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 1,000 | 2,000 | 2,000 | 2,000 | 555,000 |
Accounts payable and accrued liabilities | 1,610,000 | 1,404,000 | 1,559,000 | 1,633,000 | 1,686,000 |
TOTAL | $1,759,000 | $1,551,000 | $1,707,000 | $1,776,000 | $2,389,000 |
Non-Current Liabilities | |||||
Long Term Debt | 4,006,000 | 4,008,000 | 4,010,000 | 4,013,000 | 4,018,000 |
Other Non-Current Liabilities | 1,353,000 | 1,343,000 | 1,403,000 | 1,391,000 | 1,267,000 |
TOTAL | $5,381,000 | $5,370,000 | $5,434,000 | $5,441,000 | $5,308,000 |
Total Liabilities | $7,140,000 | $6,921,000 | $7,141,000 | $7,217,000 | $7,697,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 122,675 | 122,181 | 130,638 | 133,455 | 134,766 |
Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
Retained earnings | 7,333,000 | 10,246,000 | 9,690,000 | 9,303,000 | 8,800,000 |
Other shareholders' equity | 27,000 | 31,000 | 14,000 | 29,000 | 4,000 |
TOTAL | $6,432,000 | $5,940,000 | $6,790,000 | $6,809,000 | $6,446,000 |
Total Liabilities And Equity | $13,572,000 | $12,861,000 | $13,931,000 | $14,026,000 | $14,143,000 |